Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance
CLEAR
1 other identifier
interventional
2,140
1 country
24
Brief Summary
This randomized controlled trial will compare strategies to reduce the risk of methicillin-resistant Staphylococcus aureus (MRSA) infection and re-hospitalization in MRSA carriers. This trial will provide critical answers about the role of decolonization versus standard-of-care education in preventing MRSA infections in the large group of high risk MRSA-positive patients being discharged from hospitals. Findings could potentially impact best practice for the 1.8 million MRSA carriers who are discharged from US hospitals each year.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2011
Longer than P75 for not_applicable
24 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 23, 2010
CompletedFirst Posted
Study publicly available on registry
September 27, 2010
CompletedStudy Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2019
CompletedResults Posted
Study results publicly available
September 17, 2020
CompletedNovember 21, 2025
November 1, 2025
8 years
September 23, 2010
August 12, 2019
November 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time to MRSA Infection
Time in days to MRSA inpatient or outpatient infection (analyzed with the use of unadjusted Cox proportional-hazard models to identify time to infection; the results we are reporting are number of participants who had an infection event at one year post discharge)
1 year
Secondary Outcomes (1)
Time to All-cause Infection (Steering Committee Modified Oct 2011)
1 year
Other Outcomes (4)
Number of MRSA Infections
1 year
Rehospitalization Due to MRSA Infection
1 year
Cost and Cost Savings Associated With Post-discharge MRSA Decolonization
1 year
- +1 more other outcomes
Study Arms (2)
MRSA Decolonization
ACTIVE COMPARATORParticipants in this arm will be instructed to complete a decolonization regimen that will involve a 5-day application of nasal mupirocin, oral CHG rinse, and CHG body wash twice a month.
Education Arm
ACTIVE COMPARATORPatients randomized to standard education will receive a binder with MRSA educational materials which will include or be based upon CDC guidance for MRSA patients at home. In addition, educational material on hygiene practices to prevent MRSA infection will be provided.
Interventions
Patients randomized to standard education will receive a binder with MRSA educational materials which will include or be based upon CDC guidance for MRSA patients at home.
Participants in this arm will be instructed to complete a decolonization regimen that will involve a 5-day application of nasal mupirocin, oral CHG rinse, and CHG body wash twice a month.
Eligibility Criteria
You may qualify if:
- \) At least 18 years old
- \) Have had a positive culture (a type of test) for MRSA during recent hospital admission or within the 30 days prior to admission or following discharge
- \) Able to give consent or have a primary caregiver provide consent
- \) Able to bathe or shower or have this consistently performed by a willing caregiver
You may not qualify if:
- \) Known allergies to chlorhexidine or mupirocin
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (24)
Covington Care Center
Aliso Viejo, California, 92656, United States
West Anaheim Extended Care
Anaheim, California, 92804, United States
Downey Regional Medical Center
Downey, California, 90241, United States
Fountain Valley Regional Hospital & Medical Center
Fountain Valley, California, 92708, United States
Orange Coast Memorial Medical Center
Fountain Valley, California, 92708, United States
St. Jude Medical Center
Fullerton, California, 92835, United States
Chapman Care Center
Garden Grove, California, 92840, United States
Pacific Haven HealthCare Center
Garden Grove, California, 92843, United States
Regents Point at Windcrest
Irvine, California, 92612, United States
Saddleback Memorial Medical Center - Laguna Hills
Laguna Hills, California, 92653, United States
Long Beach Memorial Medical Center
Long Beach, California, 90806, United States
St. Mary Medical Center
Long Beach, California, 90813, United States
Mission Hospital
Mission Viejo, California, 92691, United States
Hoag Memorial Hospital Presbyterian
Newport Beach, California, 92658, United States
Villa Elena Health Care Center
Norwalk, California, 90650, United States
UC Irvine Medical Center
Orange, California, 92868, United States
Saddleback Memorial Medical Center - San Clemente
San Clemente, California, 92673, United States
Little Company of Mary - San Pedro
San Pedro, California, 90732, United States
Country Villa Plaza
Santa Ana, California, 92707, United States
Royale Healthcare
Santa Ana, California, 92707, United States
Torrance Memorial Medical Center
Torrance, California, 90505, United States
Providence Little Company of Mary Medical Center
Torrance, California, 90732, United States
Harbor-UCLA Medical Center
Torrence, California, 90502, United States
Ventura County Medical Center
Ventura, California, 93003, United States
Related Publications (5)
Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis. 2007 Dec;13(12):1840-6. doi: 10.3201/eid1312.070629.
PMID: 18258033BACKGROUNDHuang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis. 2003 Feb 1;36(3):281-5. doi: 10.1086/345955. Epub 2003 Jan 17.
PMID: 12539068BACKGROUNDHuang SS, Hinrichsen VH, Stulgis L, Miroshnik I, Datta R, Watson K, Platt R. Methicillin-resistant Staphylococcus aureus Infection in the Year Following Detection of Carriage (oral presentation). Society of Healthcare Epidemiology of America Annual Meeting (Chicago, IL), March 18-21, 2006.
BACKGROUNDKlevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK; Active Bacterial Core surveillance (ABCs) MRSA Investigators. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007 Oct 17;298(15):1763-71. doi: 10.1001/jama.298.15.1763.
PMID: 17940231BACKGROUNDHuang SS, Singh R, McKinnell JA, Park S, Gombosev A, Eells SJ, Gillen DL, Kim D, Rashid S, Macias-Gil R, Bolaris MA, Tjoa T, Cao C, Hong SS, Lequieu J, Cui E, Chang J, He J, Evans K, Peterson E, Simpson G, Robinson P, Choi C, Bailey CC Jr, Leo JD, Amin A, Goldmann D, Jernigan JA, Platt R, Septimus E, Weinstein RA, Hayden MK, Miller LG; Project CLEAR Trial. Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers. N Engl J Med. 2019 Feb 14;380(7):638-650. doi: 10.1056/NEJMoa1716771.
PMID: 30763195DERIVED
Results Point of Contact
- Title
- Susan Huang, Principal Investigator & Medical Director of Epidemiology and Infection Prevention
- Organization
- University of California, Irvine
Study Officials
- PRINCIPAL INVESTIGATOR
Susan S Huang, MD, MPH
University of California, Irivne - School of Medicine
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Epidemiology and Infection Prevention
Study Record Dates
First Submitted
September 23, 2010
First Posted
September 27, 2010
Study Start
January 1, 2011
Primary Completion
January 1, 2019
Study Completion
January 1, 2019
Last Updated
November 21, 2025
Results First Posted
September 17, 2020
Record last verified: 2025-11